Biota Holdings
E419031
Biota Holdings is an Australian biotechnology company best known for discovering and developing antiviral drugs, including the influenza medication zanamivir.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Biota Holdings canonical | 1 |
| Biota Pharmaceuticals | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4200572 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Biota Holdings Context triple: [zanamivir, developedBy, Biota Holdings]
-
A.
Kingdom Holding Company
Kingdom Holding Company is a Saudi Arabian investment conglomerate chaired by Prince Alwaleed bin Talal, known for its global portfolio spanning real estate, banking, hospitality, and media.
-
B.
Signa Holding
Signa Holding is an Austrian-based real estate and retail investment group known for owning and managing major department store and commercial property portfolios across Europe.
-
C.
Blairmore Holdings
Blairmore Holdings was an offshore investment fund associated with former UK Prime Minister David Cameron’s family that became widely known during the Panama Papers revelations.
-
D.
Recticel group
Recticel group is a Belgian industrial company best known as a major European producer of polyurethane foam and related comfort and insulation solutions.
-
E.
Predators Holdings LLC
Predators Holdings LLC is the ownership group that controls the NHL’s Nashville Predators franchise.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Biota Holdings Target entity description: Biota Holdings is an Australian biotechnology company best known for discovering and developing antiviral drugs, including the influenza medication zanamivir.
-
A.
Kingdom Holding Company
Kingdom Holding Company is a Saudi Arabian investment conglomerate chaired by Prince Alwaleed bin Talal, known for its global portfolio spanning real estate, banking, hospitality, and media.
-
B.
Signa Holding
Signa Holding is an Austrian-based real estate and retail investment group known for owning and managing major department store and commercial property portfolios across Europe.
-
C.
Blairmore Holdings
Blairmore Holdings was an offshore investment fund associated with former UK Prime Minister David Cameron’s family that became widely known during the Panama Papers revelations.
-
D.
Recticel group
Recticel group is a Belgian industrial company best known as a major European producer of polyurethane foam and related comfort and insulation solutions.
-
E.
Predators Holdings LLC
Predators Holdings LLC is the ownership group that controls the NHL’s Nashville Predators franchise.
- F. None of above. chosen
Statements (29)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ |
| abbreviation | Biota ⓘ |
| businessModel | research and development ⓘ |
| commercializationPartner |
GlaxoSmithKline
ⓘ
surface form:
Glaxo Wellcome
GlaxoSmithKline ⓘ |
| country | Australia ⓘ |
| developedFor | influenza virus ⓘ |
| drugClassDeveloped | neuraminidase inhibitors ⓘ |
| field | antiviral drug development ⓘ |
| focusesOn | influenza treatments ⓘ |
| hasCollaboration |
GlaxoSmithKline
ⓘ
surface form:
Glaxo Wellcome
GlaxoSmithKline ⓘ |
| hasPatentOn | zanamivir-related technologies ⓘ |
| hasSuccessor |
Biota Holdings
self-linksurface differs
ⓘ
surface form:
Biota Pharmaceuticals
|
| headquartersLocation | Australia ⓘ |
| industry | biotechnology ⓘ |
| knownFor |
developing antiviral drugs
ⓘ
developing zanamivir ⓘ discovering zanamivir ⓘ |
| listedOn | Australian Securities Exchange ⓘ |
| notableDrug | zanamivir ⓘ |
| productDeveloped | zanamivir ⓘ |
| productType | antiviral drug ⓘ |
| regionServed | global ⓘ |
| researchArea |
influenza antivirals
ⓘ
respiratory viral infections ⓘ |
| specializesIn | small-molecule antivirals ⓘ |
| therapeuticArea | infectious diseases ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Biota Holdings Description of subject: Biota Holdings is an Australian biotechnology company best known for discovering and developing antiviral drugs, including the influenza medication zanamivir.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Biota Pharmaceuticals